Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Change in Inventory (2016 - 2025)

Medifast (MED) has disclosed Change in Inventory for 16 consecutive years, with -$3.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 227.99% year-over-year to -$3.0 million, compared with a TTM value of -$22.2 million through Dec 2025, down 82.36%, and an annual FY2025 reading of -$22.2 million, down 82.36% over the prior year.
  • Change in Inventory was -$3.0 million for Q4 2025 at Medifast, up from -$7.0 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $50.4 million in Q4 2021 and bottomed at -$32.0 million in Q2 2022.
  • Average Change in Inventory over 5 years is -$1.7 million, with a median of -$5.2 million recorded in 2023.
  • The sharpest move saw Change in Inventory soared 1095.72% in 2021, then crashed 1521.95% in 2025.
  • Year by year, Change in Inventory stood at $50.4 million in 2021, then plummeted by 152.4% to -$26.4 million in 2022, then skyrocketed by 86.24% to -$3.6 million in 2023, then surged by 163.97% to $2.3 million in 2024, then tumbled by 227.99% to -$3.0 million in 2025.
  • Business Quant data shows Change in Inventory for MED at -$3.0 million in Q4 2025, -$7.0 million in Q3 2025, and -$9.2 million in Q2 2025.